Latest / Vanguards of Healthcare by Bloomberg Intelligence
Penumbra Builds Clinical Support Showing Computer Assistance Can Better Address Clot
Vanguards of Health Care: Penumbra Expands CAVT Awareness “With pulmonary embolism, just like with stroke and some other things, where there’s an acute moment usually happening — the patient’s not doing well, decompressing on the table — time matters a lot. And because of the STORM-PE trial, we have the data on what that device time is in a pretty rigorous randomized study. And it just doesn’t compare to anything else out there. It’s dramatically less”, Penumbra CEO Adam Elsesser explains to Bloomberg Intelligence.
In this Vanguards of Health…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.